Screening and cloning of gene of hepatocyte protein 1 interacting with HCV core protein

World Chinese Journal of Digestology

Volumn 9, Issue 12, 2001, Pages 1379-1383

  Li, K ^a   Wang, L ^a   Cheng, J ^a   Zhang, L X ^a   Duan, H J ^a   Lu, Y Y ^a   Yang, J Z ^a   Liu, Y ^a   Hong, Y ^a   Xia, X B ^a   Wang, G ^a   Dong, J ^a   Li, L ^a   Zhong, Y W ^a   Chen, J M ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

Cloning, molecular; Gene, viral; Genetic techniques; Hepatitis C like virus genetics; Viral proteins genetics

Indexed keywords

COMPLEMENTARY DNA; CORE BINDING FACTOR; LIVER PROTEIN; VIRUS PROTEIN;

ARTICLE; GENETIC SCREENING; HEPATITIS C VIRUS; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLASMID; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; VIRAL GENETICS; YEAST;

EID: 0035686433     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Hepatitis C virus infection
2. HBV concomitant infection in HCV associated HCC
3. Hepatitis C virus infection in patients with primary liver cancer
4. The risk foctors of liver cinhosis transforming to HCC
5. Clinical evaluation of serum HCV and HBV markers in patients with liver cirrhosis and hepatocellular carcinoma
6. The significance of eaaming anti-HCC in patients with carcinoma
7. The differentiation anong livercirrhosis and prmiary hepats cellular carcinoma caued by alcohol, HCV and HBV
8. Hepatocellular carcinoma cause, treatment and metastasis
9. Short and long-term effect of interferon therapy in chronic hepatitis C
10. Effect of interferon in combination with ribavirin on the plus and minus strands of HCV RNA in patients with chronic hepatitis C
11. Short- and long-term effect of interferon therapy for chronic hepatitis C
12. Seven-years follow-up on trial of interferon alpha in patients with HCV RNA positive chronic hepatitis C
13. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
14. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation
15. Additive activation of hepatic NF-kB by ethanol and HBX or HCV core protein: Involvement of TNF-a receptor I-independent and -dependent mechanisms
16. Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro
17. The role of hepatitis C in hepatocellular carcinoma: A case control study among Egyptian patients
18. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein
19. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells
20. Hepatitis C virus core protein enhances FADD-mediated apoptosis and suppresses TRADD signaling of tumor necrosis factor receptor
21. HCV-core protein accelerates recovery from the insensitivity of liver cells to Fas-mediated apoptosis induced by an injection of anti-Fas antibody in mice
22. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis
23. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation
24. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites
25. Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TAF2
26. Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli
27. A novel genetic system to detect protein-protein interactions
28. Transcriptional repression of p53 promoter by hepatitis C virus core protein
29. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha
30. Complex formation between hepatitis C virus core protein and p21Wafl/Cip1/Sdi1
31. Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha
32. The significance of expression of CD44/CD54 in patients with chronic viral hepatitis
33. Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue
34. Translocated expression of HCV core protein inhibits apoptosis in the tissue of hepatocellular carcinoma
35. Relation between viremia level and liver disease in patients with chronic HCV infection
36. Expression of processed core protein of hepatitis C virus in mammalian cells
37. Biosynthesis and biochemical properties of the hepatitis C virus core protein
38. Comparative studies of the core gene products of two different hepatitis C virus isolates: Two alternative forms determined by a single amino acid substitution
39. Regulated processing of hepatitis C virus core protein is linked to subcellular localization
40. The native form and maturation process of hepatitis C virus core protein
41. Nuclear localization of the truncated hepatitis C virus core protein with its hydrophobic C terminus deleted
42. Homotypic interaction and multimerization of hepatitis C virus core protein
43. Interaction between hepatitis C virus core protein and E1 envelope protein
44. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates
45. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor
46. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K
47. Hepatitis C virus core protein interacts with cellular putative RNA helicase
48. Hepatitis C virus core protein interacts with a human DEAD box protein DDX3
49. Hepatitis C virus core protein binds to a DEAD box RNA helicase
50. The study of transactivating effect of HCV core protein on SV40 early promoter/enhancer
51. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice
52. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
53. Yeast mating-selection scheme for detection of protein-protein interactions